Page last updated: 2024-08-16

salicylamide and 16,16-dimethylprostaglandin f2alpha

salicylamide has been researched along with 16,16-dimethylprostaglandin f2alpha in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke, MD; Falzon, M; Milton, AS1

Other Studies

1 other study(ies) available for salicylamide and 16,16-dimethylprostaglandin f2alpha

ArticleYear
Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due
    Biochemical pharmacology, 1984, Apr-15, Volume: 33, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Cytochrome P-450 Enzyme System; Dinoprost; Electrophoresis, Polyacrylamide Gel; Endotoxins; Escherichia coli; In Vitro Techniques; Indomethacin; Intestines; Male; Microsomes, Liver; Mixed Function Oxygenases; Prostaglandins F, Synthetic; Rats; Rats, Inbred Strains; Salicylamides

1984